Interactive Roundtable Discussion: ​Interactive Roundtable: New Solutions for Old Problems. Can Non-Invasive Biomarkers be the Clue?

Time: 3:00 pm
day: Day One


As non-invasive means of sample collection show promise towards a more patient-centric approach to biomarker testing in rare disease, the industry is asking:
• How can fluid testing in lieu of tissue be used to make good treatment decisions?
• Outside oncology, where is the development of liquid biomarkers showing clinical utility?
• Particularly in neurology, how can non-invasive testing be used to determine therapeutic concentration in a desired location?